The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease

Depression is a leading cause of disability globally, with a prevalence of 3.8% among the whole population, 5% of the adult population, and 5.7% of the elderly population over 60 years of age. There is evidence that depression is linked to certain neurodegenerative diseases, one being Alzheimer’s di...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad Shehata, Islam, Masood, Waniyah, Nemr, Nouran, Anderson, Alexandra, Bhusal, Kamal, Edinoff, Amber N., Cornett, Elyse M., Kaye, Adam M., Kaye, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036213/
https://www.ncbi.nlm.nih.gov/pubmed/35466206
http://dx.doi.org/10.3390/neurolint14020025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036213/
https://www.ncbi.nlm.nih.gov/pubmed/35466206
http://dx.doi.org/10.3390/neurolint14020025

Ejemplares similares